Kelly A. Demerino
Corporate Officer/Principal at NUVO PHARMACEUTICALS INC.
Profile
Kelly A.
Demerino is currently working as the Vice President-Financial Operations at Nuvo Pharmaceuticals, Inc. Prior to this role, Ms. Demerino attended Mount Allison University, where they completed their undergraduate degree.
Kelly A. Demerino active positions
Companies | Position | Start |
---|---|---|
NUVO PHARMACEUTICALS INC. | Corporate Officer/Principal | 01/01/2021 |
Training of Kelly A. Demerino
Mount Allison University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Nuvo Pharmaceuticals, Inc.
Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |
- Stock Market
- Insiders
- Kelly A. Demerino